We observed potent, combinatorial inhibition of spheroid growth by PRT1419 and Belzutifan in PBRM1 mutant, VHL-null ccRCC cell line KRMC-2 (Figure 3D). Here, VHL is linked to nonpapillary renal cell carcinoma.